Peter J Wookey

i) Treatment of cancer stem cells from the deadly brain tumour glioblastoma with an immunotoxin made from anti-calicitonin receptor antibody conjugated to a plant toxin . ii) A novel reagent to detect programmed cell death (PCD) in cultured cells. iii) A study of the utility for diagnostic imaging using an anti-calicitonin receptor antibody conjugated to a radioactive nucleotide to monitor PCD in vivo. iv) The development of an anti-human NPY1 receptor antibody that binds the extracellular domain and identifies the active homodimer.